Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis

Hepatology

Volumn 26, Issue 3, 1997, Pages 605-610

  Houglum, Karl ^a   Ramm, Grant A ^b   Crawford, Darrell H G ^b   Witztum, Joseph L ^a   Powell, Lawrie W ^b   Chojkier, Mario ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROGENESIS; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IRON OVERLOAD; IRON STORAGE; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0030866199     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260311     Document Type: Article

References (34)

1. Bassett ML, Halliday JW, Powell LW. Genetic hemochromatosis. Semin Liver Dis 1984;4:217-227.
2. Powell LW, Bassett ML, Halliday JW. Hemochromatosis: 1980 update. Gastroenterology 1980;78:374-381.
3. Bacon BR, Tavill AT, Brittenham GM, Park CH, Recknagel RO. Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 1983;71:429-439.
4. Peters TJ, O'Connell MJ, Ward RJ. Role of free-radical mediated lipid peroxidation in the pathogenesis of hepatic damage by lysosomal disruption. In: Poli G, Cheesman HH, Dianzani MU, Slater TF, eds. Free Radicals in Liver Injury. Oxford, England: I.R.L., 1985:107-115.
5. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990;86:1991-1998.
6. Bacon BR, Park CH, Brittenham GM, O'Neil R, Tavill AS. Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload. HEPATOLOGY 1985;5:789-797.
7. Bacon BR, Healey JF, Brittenham GM, Park CH, Nunnari J, Tavill AS, Bonkovsky HL. Hepatic microsomal function in rats with chronic dietary iron overload. Gastroenterology 1986;90:1844-1853.
8. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991;324:933-940.
9. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990:63:245-247.
10. Kim S-J, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem 1989;264:402-408.
11. Win KM, Charlotte F, Mallat A, Cherqui D, Martin N, Mavier P, Preaux A-M, et al. Mitogenic effect of transforming growth factor-β1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. HEPATOLOGY 1993;18:137-145.
12. Bissell DM, Wang S-S, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-β in rat liver. J Clin Invest 1995;96:447-455.
13. Armendariz-Borunda J, Seyer JM, Kang AH, Raghow R. Regulation of TGFβ gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 1990;4:215-221.
14. Houglum K, Bedossa P, Chojkier M. TGF-β and collagen-al(I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol 1994;30:G908-G913.
15. Nakatsukasa H, Evarts RP, Hsia C, Thorgeirsson SS. Transforming growth factor-β1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest 1990;63:171-180.
16. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch H, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313:1256-1262.
17. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-363.
18. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 1994;343:645-646.
19. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-887.
20. Palinski W, Ylä-Herttuala S, Rosenfield ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990;10:325-335.
21. Chojkier M, Houglum K, Solis-Herruzo JA, Brenner DA. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J Biol Chem 1989;264:16957-16962.
22. Colton T. Statistics in medicine. Boston, MA: Little, Brown, 1974:99-150.
23. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW. Hepatic stellate cell activation in genetic hemochromatosis: lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997;26:584-592.
24. Britton RS, Ferrali M, Magiera CJ, Recknagel RO, Bacon BR. Increased prooxidant action of hepatic cytosolic low-molecular-weight iron in experimental iron overload. HEPATOLOGY 1990;11:1038-1043.
25. Bryan CF, Leech SH, Kumar P, Gaumer R, Bozelka B, Morgan J. The immune system in hereditary hemochromatosis: a quantitative and functional assessment of the cellular arm. Am J Med Sci 1991;301:55-61.
26. Holstege A, Bedossa P, Poynard T, Kollinger M, Chaput JC, Houglum K, Chojkier M. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis. HEPATOLOGY 1994;19:367-374.
27. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGFa and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995;96:2461-2468.
28. Ramm GA, Li SCY, Li L, Britton RS, O'Neill R, Kobayashi Y, Bacon BR. Chronic iron overload causes activation of rat lipocytes in vivo. Am J Physiol 1995;268:G451-G458.
29. Pietrangelo A, Gualdi R, Casalgrandi G, Geerts A, De Bleser P, Montosi G, Ventura E. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. HEPATOLOGY 1994;19:714-721.
30. Pietrangelo A, Gualdi R, Casalgrani G, Montosi G, Ventura E. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest 1995;95:1824-1831.
31. Bachem M, Meyer GD, Melchior R, Sell K-M, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. J Clin Invest 1992;89:19-27.
32. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: implication for a pathogenetic role in alcoholic liver fibrogenesis. HEPATOLOGY 1990;11:599-605.
33. Kim S-J, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB. Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 1989;264:19373-19378.
34. Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Yla-Herttuala S, Brittenham GM. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995;96:620-630.